Worldwide legislative challenges related to psychoactive drugs


NEGREI C., GALATEANU B., STAN M., BALALAU C., DUMITRU M. L. B., Ozcagli E., ...More

DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, vol.25, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 25
  • Publication Date: 2017
  • Doi Number: 10.1186/s40199-017-0180-2
  • Journal Name: DARU-JOURNAL OF PHARMACEUTICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: "New" psychoactive substances, Regulatory, Control systems, Legislation, BUPRENORPHINE, SUBSTANCES
  • Istanbul University Affiliated: Yes

Abstract

The discovery of a "new" psychoactive substance is a relatively exceptional event, while the regulatory response usually involved the assessment of risks to public health and inclusion of the novel substance in the national list of controlled substances. However, in recent years we have witnessed the rapid emergence of new chemical substances, which elude international control and pose a challenge to existing processes and a threat to the credibility of control systems. We currently review and present characteristics of these legal and illegal new substances and issues regarding their global monitoring and regulatory measures already taken, or in the process of being taken, for their control. The concept of prohibition applied in active substance-related legislation is rather hazard ridden as balance is required between the ban on substances of potential therapeutic use and the access on the market of high-risk substances.